Кйтруда
Found 1 recent publications
Today, Nov 2
06:04
Markets
Moderna Leads S&P 500 With 652% Surge Despite Volatile Cancer Trial Data
Moderna shares have surged 652% in 2026, leading the S&P 500 amid volatile trading sparked by clinical trial results for its personalized cancer vaccine developed with Merck.
Showing latest 50 articles for this tag